Explore by Category

Venetoclax as a Treatment Option for Relapsed Plasma Cell Leukemia Patients

MYELOMA NEWS - April 08, 2021

Plasma Cell Leukemia (PCL) occurs in the setting of either pre-existing multiple myeloma (labeled secondary PCL [sPCL]) or as a newly diagnosed aggressive ... Read More

Isatuximab Now FDA Approved with Kyprolis and Dex for Relapsed/Refractory Myeloma

MYELOMA NEWS - April 06, 2021

This week the FDA approved the use of the anti-CD38 monoclonal antibody isatuximab (Sarclisa) in combination with carfilzomib (Kyprolis) and dexamethasone for r... Read More

FDA Grants First anti-BCMA CAR T Approval in Multiple Myeloma for Abecma

MYELOMA NEWS - March 27, 2021

The FDA today approved the first anti-BCMA CAR T cell therapy for relapsed or refractory multiple myeloma, bringing a completely new and personalized immunother... Read More

Older Myeloma Patients Can Be Spared Long-Term Steroids

MYELOMA NEWS - March 19, 2021

A new study published in Blood shows that using long-term steroids in older multiple myeloma patients can actually be harmful and not helpful. Although the Revl... Read More

Patients Who Were COVID Positive Should Delay Surgeries

MYELOMA NEWS - March 11, 2021

Patients who tested positive for COVID-19 who have planned surgeries should delay them by at least seven weeks post-infection according researchers at the Unive... Read More

Why Some Myeloma Patients Lose the BCMA Target After BCMA-Directed Therapy

MYELOMA NEWS - March 09, 2021

Why do multiple myeloma patients relapse after B cell maturation antigen (BCMA) targeted therapy? As a flood of new BCMA-directed treatments enter the multiple ... Read More

Ide-cel CAR T Update for Relapsed / Refractory Multiple Myeloma Patients

MYELOMA NEWS - March 04, 2021

The Phase II KarMMA study results of the bb2121 CAR T therapy (ideacabtagene vicleucel, also called ide-cel) in patients with relapsed myeloma showed a response... Read More

Arthritis Drug Acute GVHD in Unrelated Allo Stem Cell Transplants

MYELOMA NEWS - February 24, 2021

Acute Graft versus Host Disease (AGvHD) is quite common following unrelated donor stem cell transplants. Severe instances of AGvHD (grade 3-4) are a major cause... Read More

A Prior Cancer Diagnosis and Later Development of Multiple Myeloma

MYELOMA NEWS - February 17, 2021

I am quite certain that most of us have wondered how on earth we ended up with multiple myeloma. There is no clear answer as to what causes myeloma. A recent No... Read More

Mass Spectrometry Brings Liquid Biopsies Closer to the Clinic

MYELOMA NEWS - February 16, 2021

Research shows for the first time that the use of Mass spectrometry (MS) on blood samples to identify small amounts of remaining myeloma after treatment may be ... Read More

Myeloma Crowd's HealthTree Cure Hub Launches Real World COVID Study Part 2

MYELOMA NEWS - February 12, 2021

You're Invited to Join the COVID / Myeloma Study Part 2 The SARS-cov-2 virus has dramatically affected myeloma patients' lives in every possible way ... Read More

COVID Vaccination Guidelines for Myeloma Patients Released

MYELOMA NEWS - February 07, 2021

Patients with myeloma, AL amyloidosis, and monoclonal gammpathaies of undetermined significance (MGUS) “are at increased risk of severe infection and... Read More

Experienced Myeloma Patient to Lead African American Chapter

MYELOMA NEWS - February 04, 2021

  Join the Myeloma African American Chapter   When Valarie Traynham of Aurora, IL had a medical appointment in 2015 to find out why she was g... Read More

Thanks to our Myeloma Crowd Community sponsors:

.                         .